Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Decibel Cannabis CoDBCCF +2.78%54 3-Year EBITDA Growth Rate is 22.40% as of Jun. 2026, which is 45% above its 10-year median of 15.50. GuruFocus rates DBCCF with a GF Score™ of 54/100 and a GF Value™ of $0.08 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 809 Drug Manufacturers companies, Decibel Cannabis Co ranks better than 72.06% on this metric.
During the past 12 months, Decibel Cannabis Co's average EBITDA Per Share Growth Rate was -64.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 22.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Decibel Cannabis Co was 70.20% per year. The lowest was -78.70% per year. And the median was 15.50% per year.
Decibel Cannabis Co (OTCPK:DBCCF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Decibel Cannabis Co 3-Year EBITDA Growth Rate Related Terms
DBCCF vs ZTS: 3-Year EBITDA Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Decibel Cannabis Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Decibel Cannabis Co 3-Year EBITDA Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Decibel Cannabis Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Decibel Cannabis Co's 3-Year EBITDA Growth Rate falls into.
Decibel Cannabis Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 22.40% mean?
Decibel Cannabis Co (DBCCF) has a 3-Year EBITDA Growth Rate of 22.40% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Decibel Cannabis Co and its competitors. This is 45% above median its historical median of 15.50. According to the industry distribution chart, Decibel Cannabis Co ranks #226 out of 809 companies in the Drug Manufacturers industry, placing it in the top 27.9%.
Is Decibel Cannabis Co's 3-Year EBITDA Growth Rate too high?
Decibel Cannabis Co's current 3-Year EBITDA Growth Rate of 22.40% is 45% above median its 10-year median of 15.50. The Drug Manufacturers industry median 3-Year EBITDA Growth Rate is 8.90. Decibel Cannabis Co's value of 22.40% is 151.7% above this industry median. Based on the distribution chart, Decibel Cannabis Co ranks #226 out of 809 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Decibel Cannabis Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Decibel Cannabis Co's 3-Year EBITDA Growth Rate compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Decibel Cannabis Co ranks #226 out of 809 companies for 3-Year EBITDA Growth Rate. This puts Decibel Cannabis Co in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 8.90. Decibel Cannabis Co's value of 22.40% is 151.7% above this benchmark. While the company's 10-year median is 15.50 vs. the industry median of 8.90, Decibel Cannabis Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Drug Manufacturers company?
The median 3-Year EBITDA Growth Rate among Drug Manufacturers companies is 8.90, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Decibel Cannabis Co's current 3-Year EBITDA Growth Rate of 22.40% is 151.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Decibel Cannabis Co and its competitors. For the Drug Manufacturers industry, the median 3-Year EBITDA Growth Rate is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Decibel Cannabis Co's current 3-Year EBITDA Growth Rate is 22.40%, which is 45% above median its own 10-year median of 15.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Decibel Cannabis Co stock overvalued right now?
Based on GuruFocus' analysis, Decibel Cannabis Co (DBCCF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.09 — trading 14.3% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 22.40%, which is 45% above median its 10-year median of 15.50 and 151.7% above the Drug Manufacturers industry median of 8.90. Decibel Cannabis Co's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Decibel Cannabis Co (DBCCF), the current 3-Year EBITDA Growth Rate is 22.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Decibel Cannabis Co (DBCCF) Overvalued in 2026?
Based on GuruFocus' analysis, Decibel Cannabis Co stock appears to be overvalued.
The current stock price of $0.09 is trading 14.3% above its estimated GF Value™ of $0.08.
GuruFocus considers Decibel Cannabis Co to be Modestly Overvalued.
Key valuation signals for DBCCF:
3-Year EBITDA Growth Rate: 22.40% (45% above median its 10-year median of 15.50)
GF Value™: $0.08 vs. price of $0.09 (14.3% above fair value)
Industry Position: 151.7% above the Drug Manufacturers median (#226 of 809)
No single metric tells the full story. See the DBCCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Decibel Cannabis Co Inc is engaged in the cannabis operations business. The company is involved in the production, distribution, and sale of recreational cannabis. All the revenues are generated in Canada. The company's revenue is comprised of wholesale sales of both products and services through its production facilities to distributors and licensed cannabis producers and the direct sale of products through its retailer locations to end customers.
54GF Score
Get the complete analysis for DBCCF
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DBCCF has been successfully added to your 
